Chemours Co Files 8-K with Financial Exhibits

Ticker: CC · Form: 8-K · Filed: 2024-03-26T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, exhibits

TL;DR

Chemours filed an 8-K with financial exhibits on 3/26/24.

AI Summary

On March 26, 2024, The Chemours Company filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures related to the company's financial performance and operations. No specific material events or transactions are detailed in the provided excerpt.

Why It Matters

This filing provides updated financial information and exhibits for The Chemours Company, which is crucial for investors and stakeholders to assess the company's financial health and operational status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report primarily containing financial statements and exhibits, with no immediate indication of significant new risks or material adverse events.

Key Numbers

Key Players & Entities

FAQ

What specific financial statements or exhibits are included in this 8-K filing?

The provided excerpt states the filing includes 'Financial Statements and Exhibits' but does not specify the exact nature or content of these documents.

Does this 8-K report announce any new material events or transactions for The Chemours Company?

The excerpt indicates the filing is for 'Regulation FD Disclosure' and 'Financial Statements and Exhibits,' but does not detail any specific new material events or transactions.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported is March 26, 2024.

Where is The Chemours Company's principal executive office located?

The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.

What is the company's standard industrial classification code?

The company's Standard Industrial Classification code is 2800, which falls under CHEMICALS & ALLIED PRODUCTS.

From the Filing

0001193125-24-077725.txt : 20240326 0001193125-24-077725.hdr.sgml : 20240326 20240326173032 ACCESSION NUMBER: 0001193125-24-077725 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240326 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24784854 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 d782971d8k.htm 8-K 8-K Chemours Co false 0001627223 0001627223 2024-03-26 2024-03-26     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 26, 2024 Date of Report (Date of Earliest Event Reported)     The Chemours Company (Exact Name of Registrant as Specified in Its Charter)       Delaware   001-36794   46-4845564 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices) Registrant’s telephone number, including area code: (302) 773-1000     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 7.01 Regulation FD Disclosure. On March 26, 2024, The Chemours Company (the “Company”) issued a press release announcing that it currently expects to issue its fourth quarter and full year 2023 financial results and file its Annual Report on Form 10-K for the year ended December 31, 2023 after market close on Wednesday, March 27, 2024, and to hold its conference call to discuss its fourth quarter and full year 2023 financial results at 8:00 a.m. Eastern Daylight Time on Thursday, March 28, 2024. A copy of the press release, which contains further information regarding the conference call, is attached hereto as Exhibit 99.1. The information furnished with this report on Form 8-K, i

View on Read The Filing